Medtronic Interest Expense, Borrowings increased by 0.5% to $223.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $224.00M to $223.00M. This is a positive signal — lower values indicate better performance for this metric.
Lower interest expense is generally preferred as it improves net income, though it depends on the company's leverage strategy and interest rate environment.
The cost incurred by the company for the use of borrowed funds, including interest on debt instruments and credit facili...
Standard metric for assessing the cost of debt across all companies with significant leverage.
is_ms_interest_expense_borrowings| Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $197.00M | $230.00M | $237.00M | $217.00M | $252.00M | $224.00M | $217.00M | $222.00M | $223.00M |
| QoQ Change | — | +16.8% | +3.0% | -8.4% | +16.1% | -11.1% | -3.1% | +2.3% | +0.5% |
| YoY Change | — | — | — | +10.2% | +9.6% | -5.5% | +0.0% | -11.9% | -0.4% |